English
TTK Healthcare Q3 Results
- BSE: 507747
- NSE: TTKHLTCARE
- ISIN: INE910C01018
- Sector: Biotechnology & Drugs
BSE
969.00
-13.05 (-1.33%)
-13.05 (-1.33%)Volume459.00
Updated: Fri 23 Jan, 2026 | 15:29:20
NSE
965.30-15.40 (-1.57%)
-15.40 (-1.57%)Volume4.68 K
Updated: Fri 23 Jan, 2026 | 15:47:31
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹209.30 Cr.(2.22%)
- Operating Profit₹-2.66 Cr.(NA%)
- Profit After Tax₹10.53 Cr.(-37.05%)
- Operating Margin-1.27%(NA%)
Note: Comparison is on YoY basis
Quarterly - TTK Healthcare Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 211.96 | 192.26 | 5.75% | 181.82 | 6.43% |
| Depreciation/ Amortization | 2.22 | 2.00 | 0.44% | 3.31 | 5.24% |
| Operating Income | -2.66 | 6.22 | 0.00% | 2.03 | 0.00% |
| Net Income | 10.53 | 17.20 | -48.34% | 12.89 | -37.05% |
| Other Operating Expenses Total | 62.82 | 62.69 | 5.98% | 60.62 | 3.67% |
| Net Income Before Taxes | 14.09 | 23.19 | -33.85% | 17.70 | -37.65% |
| Total Revenue | 209.30 | 198.49 | 2.82% | 183.85 | 2.22% |
| Selling/ General/ Admin Expenses Total | 41.73 | 37.72 | 1.51% | 32.32 | 8.59% |
| Diluted Normalized EPS | 11.46 | 12.17 | -20.60% | 9.13 | -3.23% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.